← Leaderboards
Ingrid A Mayer
Vanderbilt University
$3,073,264
Attributed
$3,073,264
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2008–21$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$10,842,054 · 7
By mechanism
P50$9,843,470 · 5
K23$819,720 · 1
P30$178,864 · 1
Top collaborators
- Jennifer A Pietenpol4 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Carlos L Arteaga$27,881,034
- Jennifer A Pietenpol$43,416,854
- Brent N Rexer$1,140,154
- Justin M Balko$6,825,551
- Yuankai Kenny Tao$4,151,264
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsBreastMalignant Breast NeoplasmSafetyBaseTranslational ResearchProgramsCollaborationsDesignTriple-Negative Invasive Breast CarcinomaEnsureResearch PersonnelHormone TherapyErbb2 GeneDatabasesProtocols DocumentationCancer PatientClinical Trials DesignGrantMonitorFutureInsightCancer BiologyOperative Surgical Procedures
Grant awards (23)
Breast Cancer Research Program$89,432
P30 · FY2021 · CA · contact PI
SPORE in Breast Cancer$2,088,032
P50 · FY2020 · CA
Breast Cancer Research Program$89,432
P30 · FY2020 · CA · contact PI
SPORE in Breast Cancer$2,218,149
P50 · FY2019 · CA
SPORE in Breast Cancer$1,162,609
P50 · FY2018 · CA
Clinical Core$206,071
P50 · FY2018 · CA · contact PI
SPORE in Breast Cancer$2,300,000
P50 · FY2017 · CA
Clinical Core$192,750
P50 · FY2017 · CA · contact PI
Clinical Core$192,270
P50 · FY2016 · CA · contact PI
Clinical Core$209,903
P50 · FY2015 · CA · contact PI
Clinical Core$101,898
P50 · FY2015 · CA · contact PI
Clinical Core$223,929
P50 · FY2014 · CA · contact PI
Targeted Therapies in Breast Cancer$163,944
K23 · FY2013 · CA · contact PI
Clinical Core$153,608
P50 · FY2013 · CA · contact PI
Clinical Core$175,981
P50 · FY2012 · CA · contact PI
Targeted Therapies in Breast Cancer$163,944
K23 · FY2012 · CA · contact PI
Clinical Core$166,448
P50 · FY2011 · CA · contact PI
Targeted Therapies in Breast Cancer$163,944
K23 · FY2011 · CA · contact PI
Clinical Core$166,092
P50 · FY2010 · CA · contact PI
Targeted Therapies in Breast Cancer$163,944
K23 · FY2010 · CA · contact PI
Clinical Core$173,648
P50 · FY2009 · CA · contact PI
Targeted Therapies in Breast Cancer$163,944
K23 · FY2009 · CA · contact PI
Clinical Core$112,082
P50 · FY2008 · CA · contact PI